Susnjar S - Search Results

1

Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.

Tanić M, Krivokuća A, Čavić M, Mladenović J, Plesinac Karapandžić V, Beck S, Radulović S, Susnjar S, Janković R. Tanić M, et al. Among authors: susnjar s. Radiat Oncol. 2018 Oct 1;13(1):193. doi: 10.1186/s13014-018-1129-4. Radiat Oncol. 2018. PMID: 30285791 Free PMC article.

2

Therapeutic and endocrine effects of Decapeptyl, synthetic LH-RH agonistic analogue in premenopausal women with metastatic breast cancer. A pilot phase II study.

Nesković-Konstantinović ZB, Vuletić LB, Nikolić-Stanojević LI, Susnjar SV, Jelić SB, Branković-Magić MV, Radulović SS. Nesković-Konstantinović ZB, et al. Among authors: susnjar sv. Oncology. 1994 Jan-Feb;51(1):95-101. doi: 10.1159/000227318. Oncology. 1994. PMID: 8265112 Clinical Trial.

3

Tumour-induced hypercalcaemia, resistant to systemic anti-hypercalcaemic and chemo-endocrine treatments, but responding to radiotherapy in a breast cancer patient.

Nesković-Konstantinović Z, Susnjar S, Vasović S, Borojević N, Mitrović L, Radosević-Jelić L, Radulović S. Nesković-Konstantinović Z, et al. Among authors: susnjar s. Acta Oncol. 1996;35(4):501-3. doi: 10.3109/02841869609109934. Acta Oncol. 1996. PMID: 8695173 No abstract available.

4

Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: a phase II study.

Susnjar S, Vasović S, Nesković-Konstantinović Z, Stamatović L, Lukić V, Colaković S, Mitrovic L, Jelić S, Radulović S. Susnjar S, et al. Tumori. 1999 Nov-Dec;85(6):478-82. doi: 10.1177/030089169908500610. Tumori. 1999. PMID: 10774569 Clinical Trial.

5

High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.

Bosnjak SM, Nesković-Konstantinović ZB, Radulović SS, Susnjar S, Mitrovi LB. Bosnjak SM, et al. Among authors: susnjar s. J Chemother. 2000 Oct;12(5):446-53. doi: 10.1179/joc.2000.12.5.446. J Chemother. 2000. PMID: 11128567 Clinical Trial.

6

[Trastuzumab in metastatic breast carcinoma].

Susnjar S, Bosnjak S, Radulovic S. Susnjar S, et al. Srp Arh Celok Lek. 2001 May-Jun;129(5-6):147-52. Srp Arh Celok Lek. 2001. PMID: 11797464 Review. Serbian. No abstract available.

7

Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.

Susnjar S, Bosnjak S, Radulovic S, Stevanovic J, Gajic-Dobrosavljevic M, Kreacic M. Susnjar S, et al. J BUON. 2007 Apr-Jun;12(2):189-96. J BUON. 2007. PMID: 17600871 Clinical Trial.

8

Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.

Mladenovic J, Susnjar S, Gavrilovic D, Borojevic N. Mladenovic J, et al. Among authors: susnjar s. J BUON. 2007 Apr-Jun;12(2):215-20. J BUON. 2007. PMID: 17600875

9

Severe skin toxicity observed with the combination of capecitabine and weekly paclitaxel in metastatic breast cancer patients.

Susnjar S, Bosnjak SM, Radulovic S. Susnjar S, et al. Support Care Cancer. 2008 Dec;16(12):1415-8. doi: 10.1007/s00520-008-0495-0. Epub 2008 Sep 5. Support Care Cancer. 2008. PMID: 18773227 Clinical Trial.

10

PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen.

Milovanovic Z, Dzodic R, Susnjar S, Plesinac-Karapandzic V, Juranic Z, Tatic S. Milovanovic Z, et al. Among authors: susnjar s. J BUON. 2011 Jan-Mar;16(1):46-51. J BUON. 2011. PMID: 21674849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters